Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.

BACKGROUND: Surgery for colorectal liver metastases results in an overall survival of about 40% at 5 years. Progression-free survival is increased with the addition of oxaliplatin and fluorouracil chemotherapy. The addition of cetuximab to these chemotherapy regimens results in an overall survival a...

Full description

Bibliographic Details
Main Author: Bouchahda, M (author)
Other Authors: Boige, V (author), Smith, D (author), Karaboué, A (author), Ducreux, M (author), Hebbar, M (author), Lepére, C (author), Focan, C (author), Guimbaud, R (author), Innominato, P (author), Awad, S (author), Carvalho, C (author), Tumolo, S, et al. (author)
Format: article
Language:eng
Published: 2016
Subjects:
Colorectal neoplasms
Antineoplastic combined chemotherapy protocols
Neoplasm metastasis
Neoplasias colorrectais
Online Access:http://hdl.handle.net/10400.10/1766
Country:Portugal
Oai:oai:repositorio.hff.min-saude.pt:10400.10/1766

Internet

http://hdl.handle.net/10400.10/1766

Similar Items